| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 9.239 | 13.993 | 14.870 | 15.173 | 18.174 | 15.682 | 19.988 | 20.786 | 24.441 | 26.362 |
| Total Income - EUR | 9.718 | 14.168 | 15.015 | 15.340 | 18.697 | 15.940 | 20.096 | 20.909 | 24.445 | 26.368 |
| Total Expenses - EUR | 4.871 | 7.096 | 6.923 | 8.416 | 14.083 | 9.498 | 9.696 | 6.465 | 15.202 | 14.034 |
| Gross Profit/Loss - EUR | 4.847 | 7.072 | 8.092 | 6.924 | 4.614 | 6.442 | 10.400 | 14.444 | 9.243 | 12.334 |
| Net Profit/Loss - EUR | 4.556 | 6.647 | 7.641 | 6.463 | 4.053 | 5.964 | 9.809 | 13.817 | 9.004 | 11.559 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Art-Med Consult Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 7.348 | 5.792 | 3.513 | 12.905 | 8.155 | 4.626 | 1.331 | 0 | 0 | 528 |
| Current Assets | 13.761 | 24.133 | 32.570 | 21.354 | 22.869 | 24.205 | 36.349 | 19.666 | 18.111 | 27.847 |
| Inventories | 0 | 0 | 0 | 0 | 12 | 0 | 24 | 0 | 0 | 0 |
| Receivables | 2.093 | 2.897 | 2.227 | 969 | 1.993 | 774 | 2.053 | 2.345 | 2.528 | 712 |
| Cash | 11.669 | 21.236 | 30.343 | 20.385 | 20.864 | 23.432 | 34.272 | 17.321 | 15.583 | 27.135 |
| Shareholders Funds | 15.580 | 6.700 | 7.694 | 6.515 | 10.441 | 16.207 | 19.577 | 13.865 | 9.052 | 11.607 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.529 | 23.225 | 28.324 | 27.744 | 20.582 | 12.625 | 18.103 | 5.800 | 9.059 | 16.768 |
| Income in Advance | 0 | 0 | 66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8512 - 8512" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Art-Med Consult Srl